Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 31 Issue 2
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2013  >  31(2): 143-144,150

LI Yu-qing. Cost-effectiveness analysis of three kinds of drugs for osteoporosis[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 143-144,150. doi: 10.3969/j.issn.1006-0111.2013.02.018
Citation: LI Yu-qing. Cost-effectiveness analysis of three kinds of drugs for osteoporosis[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 143-144,150. doi: 10.3969/j.issn.1006-0111.2013.02.018
shu

Cost-effectiveness analysis of three kinds of drugs for osteoporosis

doi: 10.3969/j.issn.1006-0111.2013.02.018

  • Wenling First People's Hospital of Zhejiang Province, Wenling 317500, China

  • Received Date: 2012-05-03
  • Rev Recd Date: 2012-10-29
  • Objective To investigate economic effects of three kinds of drugs in treatment of osteoporosis. Methods 135 cases were divided into three groups, A group with alendronate sodium and vitamin D3 tablets 70 mg/2 800 IU, once a week, early morning,B group with salmon calcitonin nasal spray, once a day every time 100 IU, C group with zoledronicacid injection 4 mg, once a year. All groups were treated for one year, three groups of patients were added calcium at the same time. Efficacy was observed. Cost-effectiveness analysis was used. Results In the improvement of bone pain, A group was 66.67%, B group was 55.56%, C group was 80%. C group was higher than those in group A, group B, group efficacy was statistically significant in three groups(P<0.05); The effectiveness ratio of A group, B group, C group was 59.52,43.61,46.70 respectively. B group was superior to A group and C group in the terms of economic, but group B had the lowest efficacy in all groups. Conclusion C group was the optimal solution for osteoporosis.
  • [1] 林 志. 阿仑膦酸钠治疗老年骨质疏松症的临床观察[J]. 齐齐哈尔医学院学报,2009,30(21):2632.
    [2] Bonnick SL. Osteoporosis in men and women[J]. Clin Cornerston,2006,8(1):28
    [3] 陈 洁.药物经济学[M].第3版.成都:成都科技大学出版社,2000:97.
    [4] 艾伟朋,方红成.三种他汀类药物治疗高脂血症的经济学分析[J]. 现代医药卫生,2005, 21(10):1200.
    [5] 孔晓东. 药物经济学:概念、方法和应用[J].国外医学药学分册,1994,21(1):16.
    [6] 蒋凤艳.原发性骨质疏松症的发病机制和预防[J].广西医科大学学报,2004,21(3):437.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(2871) PDF downloads(100) Cited by()

Related
Proportional views

Cost-effectiveness analysis of three kinds of drugs for osteoporosis

doi: 10.3969/j.issn.1006-0111.2013.02.018
  • Wenling First People's Hospital of Zhejiang Province, Wenling 317500, China
  • Received Date: 2012-05-03
  • Rev Recd Date: 2012-10-29

Abstract: Objective To investigate economic effects of three kinds of drugs in treatment of osteoporosis. Methods 135 cases were divided into three groups, A group with alendronate sodium and vitamin D3 tablets 70 mg/2 800 IU, once a week, early morning,B group with salmon calcitonin nasal spray, once a day every time 100 IU, C group with zoledronicacid injection 4 mg, once a year. All groups were treated for one year, three groups of patients were added calcium at the same time. Efficacy was observed. Cost-effectiveness analysis was used. Results In the improvement of bone pain, A group was 66.67%, B group was 55.56%, C group was 80%. C group was higher than those in group A, group B, group efficacy was statistically significant in three groups(P<0.05); The effectiveness ratio of A group, B group, C group was 59.52,43.61,46.70 respectively. B group was superior to A group and C group in the terms of economic, but group B had the lowest efficacy in all groups. Conclusion C group was the optimal solution for osteoporosis.

LI Yu-qing. Cost-effectiveness analysis of three kinds of drugs for osteoporosis[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 143-144,150. doi: 10.3969/j.issn.1006-0111.2013.02.018
Citation: LI Yu-qing. Cost-effectiveness analysis of three kinds of drugs for osteoporosis[J]. Journal of Pharmaceutical Practice and Service, 2013, 31(2): 143-144,150. doi: 10.3969/j.issn.1006-0111.2013.02.018
shu

    HTML

Reference (6)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return